MeSH D010003 - osteoarthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Aspirin, Methocarbamol | Robaxisal |  | 1982-01-01 |  |  |
| AAIPharma | Aspirin, Propoxyphene napsylate | Darvon-n W/ Asa |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Aspirin, Hydrocodone | Vicoprin |  | 1983-09-14 |  |  |
| Ibuprofen | Ibu |  | 1989-12-18 |  |  | |
| Ibuprofen | Ibuprofen |  | 1985-06-14 |  |  | |
| AbbVie | Ibuprofen, Hydrocodone | Vicoprofen |  | 1997-09-23 |  |  |
| Able Laboratories | Indomethacin | Indomethacin |  | 2002-02-06 |  |  |
| Naproxen | Naproxen |  | 2003-08-22 |  |  | |
| ACIC Pharmaceuticals | Celecoxib | Celecoxib |  | 2020-12-09 |  |  |
| Ajanta Pharma | Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  |
| Akorn | Diclofenac | Diclofenac |  | 2008-04-17 |  |  |
| Alembic Pharmaceuticals | Diclofenac | Diclofenac |  | 2022-07-27 |  |  |
| Celecoxib | Celecoxib |  | 2015-08-21 |  |  | |
| Alkem Laboratories | Ibuprofen | Ibuprofen |  | 2021-09-13 |  |  |
| Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-08-03 |  |  |
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
90%35/39
Phase 2
58%47/81
Phase 3
75%79/105
Approved: 25Overall Success rate: 39%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use